Improve Medical Instruments Co., Ltd.
SZSE:300030.SZ
7.42 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 581.328 | 644.621 | 710.768 | 799.834 | 919.226 | 575.061 | 549.963 | 549.653 | 517.103 | 545.349 | 461.792 | 396.737 | 304.085 | 249.639 | 165.866 | 140.793 | 103.448 | 72.321 | 44.121 |
| Cost of Revenue
| 340.699 | 410.905 | 446.349 | 473.32 | 488.95 | 325.491 | 326.394 | 304.137 | 276.462 | 308.531 | 261.627 | 230.204 | 171.653 | 139.416 | 91.92 | 74.977 | 55.364 | 36.417 | 18.869 |
| Gross Profit
| 240.629 | 233.716 | 264.42 | 326.514 | 430.276 | 249.571 | 223.569 | 245.516 | 240.641 | 236.818 | 200.165 | 166.533 | 132.432 | 110.223 | 73.946 | 65.817 | 48.084 | 35.904 | 25.253 |
| Gross Profit Ratio
| 0.414 | 0.363 | 0.372 | 0.408 | 0.468 | 0.434 | 0.407 | 0.447 | 0.465 | 0.434 | 0.433 | 0.42 | 0.436 | 0.442 | 0.446 | 0.467 | 0.465 | 0.496 | 0.572 |
| Reseach & Development Expenses
| 31.899 | 37.521 | 43.665 | 42.328 | 46.562 | 23.506 | 25.521 | 19.417 | 26.324 | 27.218 | 24.902 | 19.028 | 17.041 | 13.706 | 0 | 0 | 4.453 | 4.602 | 0 |
| General & Administrative Expenses
| -60.06 | 38.961 | 38.839 | 34.488 | 49.232 | 36.058 | 41.643 | 37.075 | 32.052 | 29.028 | 22.163 | 21.359 | 19.981 | 13.95 | 29.297 | 17.582 | 3.539 | 2.868 | 6.351 |
| Selling & Marketing Expenses
| 51.832 | 121.883 | 126.047 | 112.948 | 117.746 | 95.691 | 98.266 | 90.862 | 96.801 | 96.79 | 76.391 | 61.511 | 48.872 | 36.941 | 21.591 | 17.59 | 12.963 | 10.386 | 8.513 |
| SG&A
| -8.229 | 160.977 | 164.886 | 147.436 | 166.978 | 131.749 | 139.909 | 127.937 | 128.853 | 125.818 | 98.554 | 82.87 | 68.852 | 50.891 | 50.888 | 35.172 | 16.501 | 13.254 | 14.864 |
| Other Expenses
| 333.888 | 76.031 | 72.015 | 74.253 | 45.093 | 47.33 | -0.172 | -0.005 | 15.735 | 11.541 | 12.466 | 15.042 | 12.691 | 6.563 | 5.84 | 2.101 | 4.421 | 0.694 | -0.044 |
| Operating Expenses
| 357.558 | 274.53 | 280.566 | 264.017 | 258.634 | 202.585 | 211.474 | 185.73 | 201.071 | 187.758 | 148.89 | 124.595 | 102.053 | 75.025 | 51.235 | 35.733 | 27.552 | 21.273 | 15.136 |
| Operating Income
| -116.929 | -40.813 | -16.147 | 82.928 | 255.415 | 69.398 | -144.318 | 16.933 | 24.795 | 38.243 | 53.514 | 44.749 | 34.814 | 40.057 | 27.623 | 28.786 | 19.738 | 15.266 | 9.896 |
| Operating Income Ratio
| -0.201 | -0.063 | -0.023 | 0.104 | 0.278 | 0.121 | -0.262 | 0.031 | 0.048 | 0.07 | 0.116 | 0.113 | 0.114 | 0.16 | 0.167 | 0.204 | 0.191 | 0.211 | 0.224 |
| Total Other Income Expenses Net
| -3.417 | -2.249 | -1.456 | -6.044 | -0.899 | -0.574 | -0.172 | -0.005 | 15.716 | 11.537 | 12.423 | 15.033 | 12.652 | 8.385 | 11.114 | 2.101 | 4.421 | 0.694 | -0.034 |
| Income Before Tax
| -120.346 | -43.062 | -214.297 | 23.841 | 165.087 | 37.001 | -144.49 | 16.929 | 40.511 | 49.78 | 65.937 | 59.782 | 47.466 | 46.62 | 33.463 | 30.887 | 24.159 | 15.959 | 9.862 |
| Income Before Tax Ratio
| -0.207 | -0.067 | -0.302 | 0.03 | 0.18 | 0.064 | -0.263 | 0.031 | 0.078 | 0.091 | 0.143 | 0.151 | 0.156 | 0.187 | 0.202 | 0.219 | 0.234 | 0.221 | 0.224 |
| Income Tax Expense
| -0.447 | 17.158 | -21.006 | 4.072 | 1.765 | 10.863 | -3.498 | 8.683 | 10.016 | 8.498 | 9.192 | 8.232 | 4.717 | 6.275 | 4.443 | 3.982 | 3.697 | 2.769 | 1.517 |
| Net Income
| -117.904 | -63.204 | -193.291 | 18.569 | 162.515 | 26.024 | -136.801 | 11.158 | 30.477 | 39.835 | 53.057 | 46.12 | 37.472 | 35.675 | 29.021 | 26.905 | 20.462 | 13.19 | 8.345 |
| Net Income Ratio
| -0.203 | -0.098 | -0.272 | 0.023 | 0.177 | 0.045 | -0.249 | 0.02 | 0.059 | 0.073 | 0.115 | 0.116 | 0.123 | 0.143 | 0.175 | 0.191 | 0.198 | 0.182 | 0.189 |
| EPS
| -0.38 | -0.2 | -0.63 | 0.06 | 0.53 | 0.084 | -0.44 | 0.04 | 0.1 | 0.13 | 0.18 | 0.16 | 0.13 | 0.12 | 0.1 | 0.13 | 0.11 | 0.073 | 0.21 |
| EPS Diluted
| -0.38 | -0.2 | -0.63 | 0.06 | 0.53 | 0.084 | -0.44 | 0.04 | 0.1 | 0.13 | 0.18 | 0.16 | 0.13 | 0.12 | 0.1 | 0.13 | 0.11 | 0.073 | 0.21 |
| EBITDA
| -69.408 | 17.738 | -19.688 | 102.596 | 227.258 | 99.324 | -71.3 | 81.218 | 99.38 | 95.437 | 100.234 | 83.494 | 66.224 | 56.45 | 43.758 | 36.649 | 28.205 | 16.881 | 11.7 |
| EBITDA Ratio
| -0.119 | 0.028 | -0.028 | 0.128 | 0.247 | 0.173 | -0.13 | 0.148 | 0.192 | 0.175 | 0.217 | 0.21 | 0.218 | 0.226 | 0.264 | 0.26 | 0.273 | 0.233 | 0.265 |